Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Bioanalysis|December 15, 2015
From low- to high-throughput analysisAnn Lévesque, Sofi Gagnon-Carignan, Sylvain LachanceBioanalysis|January 15, 2015
Justifying the lack of incurred sample reproducibility in a study: considerations and strategiesSofi Gagnon-Carignan, Sylvain Lachance, Audrey Saint-Laurent, et al.Bioanalysis|May 7, 2011
Beyond successful ISR: case-by-case investigations for unmatched reassay results when ISR passedAimin Tan, Sofi Gagnon-Carignan, Sylvain Lachance, et al.Bioanalysis|April 20, 2012
4th Global CRO Council for Bioanalysis: coadministered drugs stability, EMA/US FDA guidelines, 483s and carryoverSteve Lowes, Jim Jersey, Ronald Shoup, et al.Bioanalysis|June 18, 2011
Recommendations on: internal standard criteria, stability, incurred sample reanalysis and recent 483s by the Global CRO Council for BioanalysisSteve Lowes, Jim Jersey, Ronald Shoup, et al.Bioanalysis|December 16, 2014
8th GCC: consolidated feedback to US FDA on the 2013 draft FDA guidance on bioanalytical method validationJoseph Bower, Douglas Fast, Fabio Garofolo, et al.Bioanalysis|September 28, 2012
Recommendations on bioanalytical method stability implications of co-administered and co-formulated drugs by Global CRO Council for Bioanalysis (GCC)Steve Lowes, Mark Boterman, Mira Doig, et al.Pageof 1